Get your free ETF data sample from our comprehensive offerings. Start your free trial→

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

›ETF Providers›VanEck›CIB0

CIB0 ETF · Vaneck Bionic Engineering Ucits ETF

The CIB0 Exchange Traded Fund (ETF) is provided by VanEck. It is built to track an index: MVIS Global Bionic Healthcare ESG Index. The CIB0 ETF provides physical exposure, so by buying it you actually own parts of all the 25 underlying holdings. The dividend policy is capitalization.
Real-time data unavailable for CIB0
LIVE
CLOSED
This fund is part ofWorld Blended Cap1M perf.-4.08%
Last price
N/A
1M perf.
-5.49%
1M flows
N/A
AuM
€9.1M
E/R
0.55%
Rating
ESG Consensus®
esg grade icon
CIB0
N/A

Performance & flows

Segment for quartile rank
December 12, 2025 → March 12, 2026
0-10-8-6-4-20246%JANFEBMAR
Create a free account to view the flows graph
CIB0
$19.13
-8.57%
World Blended Cap
+1.00%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-5.49%
icon
-8.57%
icon
-2.11%
icon
-4.95%
icon
N/A
-8.54%
-7.99%
-7.99%
icon
Flows

Key fund info

Segment for quartile rank
Main characteristics
Issuer
ISIN
IE0005TF96I9
AuM
€9.1M
icon
E/R
0.55%
icon
Replication rating
icon
ESG Consensus®
esg grade icon
icon
More details
NAV
3/12/2026
$19.13
1D NAV change
-2.09%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
25
Inception date
12/2/2022
Jurisdiction
Ireland
Distribution
Switzerland
Austria
Denmark
Finland
France
Legal structure
Open-end Investment Company
Base currency
USD
Classification
Product type
Benchmark
MVIS Global Bionic Healthcare ESG Index
Asset class
Factors
N/A
Investment strategy
VanEck’s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
See all Trackinsight Enterprise features

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight Enterprise

Similar ETFs

CURE
1M perf.
-3.05%
E/R
0.35%
GDOC
1M perf.
-3.58%
E/R
0.75%
HTEC
1M perf.
-4.76%
E/R
0.8%
DOCG
1M perf.
-6.78%
E/R
0.49%
UMDV
1M perf.
-4.98%
E/R
0.25%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
-8.57%
icon
-2.11%
icon
-4.95%
icon
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
1
2
3
4
5
6
7
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Exposure

Countries
USA
69.43%
Ireland
10.29%
Switzerland
8.95%
Australia
3.73%
Cayman Islands
3.69%
Italy
2.49%
Denmark
1.42%
Sectors
Health Care
97.07%
Unavailable
2.93%
Diversification
Total weight of top 15 holdings out of 25
Top 15 holdings
Data as of January 31, 2026
STRYKER
MEDTRONIC PLC
INTUITIVE SURGICAL
EDWARDS LIFESCIENCES
DEXCOM
STRAUMANN
SONOVA
ZIMMER BIOMET HOLDINGS INC
Create a free account to view top holdings
INSULET
COCHLEAR ORDINARY
GLOBUS MEDICAL
GLAUKOS
US83175M2052
INTEGER HOLDINGS
TRANSMEDICS GROUP
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Sustainability

Integrates ESG criteria
Yes
SDG

ESG Consensus® by Conser

Data as of December 31, 2025
Methodology

Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about CIB0 ETF's sustainability, based on their methodology.

Learn more about Conser

ESG Consensus®
esg grade icon

ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.


CIB0’s has a Final Sustainability Grade of either A+, A, or A-.

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise
Holdings review
92.06% of holdings have positive scoring
7.92% of holdings have negative scoring
12.25%
53.16%
26.65%
5.43%
Consensus levels
Strong
Medium
Weak
No data on remaining < 1% of holdings
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Replication

Trackinsight replication rating:
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
MVIS Global Bionic Healthcare ESG Index (NTR) - USD
Index ticker
MVBIONTR Index
Index dividend policy
NTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Issuer

VanEck
VanEck ID Card
Number of funds
174
Total AuM
€183.56B
Expense ratio range
0.07% - 12.86%
Average expense ratio
0.6804%
Top 5 funds by VanEck
AuM
SMH
VanEck Semiconductor ETF€39.58B
GDX
VanEck Gold Miners ETF€28.01B
MOAT
VanEck Morningstar Wide Moat ETF€10.66B
GDXJ
VanEck Junior Gold Miners ETF€9.19B
DFEN
VanEck Defense UCITS ETF€8.17B

Through forward-looking, intelligently designed active and ETF solutions, VanEck offers value-added exposures to emerging industries, asset classes and markets as well as differentiated approaches to traditional strategies. Global player based in New York, founded in 1955, ranked among the 10 best providers of ETFs in the United States, VanEck also has a strong presence in Europe (Germany, Switzerland, the Netherlands) as well as a presence in Asia and Australia. VanEck is different from other asset managers by being privately held, allowing them to focus on clients’ long-term interests, constantly been at the forefront of innovation and whose ETFs are transparent with no synthetic replication and no lent out.

Via Offical website

Frequently asked questions about CIB0

What does Vaneck Bionic Engineering Ucits ETF, CIB0, invest in?

CIB0 is a Passive ETF. This ETF provides exposure to Equities.

Which benchmark or index does CIB0 replicate?

CIB0 tracks the MVIS Global Bionic Healthcare ESG Index (NTR) - USD, through a full replication replication method.

What is the Total Expense ratio (TER) of CIB0?

CIB0 carries a total expense ratio (TER) of 0.55%, indicating the annual cost for holding the fund.

When was CIB0 launched?

CIB0 was introduced to the market on December 2, 2022. It trades on Switzerland, among other exchanges

Who is the ETF issuer of CIB0?

Vaneck Bionic Engineering Ucits ETF, CIB0, is provided by VanEck. Learn more about VanEck here.

What is the current assets under management (AUM) of CIB0?

CIB0 oversees €9.1M in assets as of March 12, 2026.

How has CIB0 performed lately?

Based on data from March 12, 2026, CIB0 returned -5.49% over the past month, -8.57% over the last three months and -7.99% year-to-date.

What are the latest inflows or outflows for CIB0?

As of March 12, 2026, CIB0 recorded net flows of +€1.8M year-to-date.

Does CIB0 distribute dividends?

CIB0 follows a capitalizing, meaning it reinvests income within the fund.

What are the main country or region exposures of CIB0?

As of January 31, 2026, CIB0 has significant geographic allocations in USA, Ireland and Switzerland.

In which sector or theme does CIB0 invest in?

As of January 31, 2026, CIB0 focuses largely on Health Care.

How many securities does CIB0 hold and how diversified is it?

As of January 31, 2026, CIB0 holds 25 positions in its portfolio, with 80.77% of assets concentrated in its top 15 holdings.

What are the main positions in CIB0?

As of January 31, 2026, CIB0 top three holdings include STRYKER, MEDTRONIC PLC and INTUITIVE SURGICAL.

What is the base currency of CIB0?

The base currency of CIB0 is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight